Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
28.30
-0.31 (-1.08%)
At close: May 19, 2026, 4:00 PM EDT
28.25
-0.05 (-0.18%)
After-hours: May 19, 2026, 7:13 PM EDT
Rigel Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Rigel Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $53.2. The average 1-year stock price forecast is 87.99% higher than the current stock price, while the lowest is $38 (+34.28%) and the highest is $81 (+186.22%).
Price Target: $53.2 (+87.99%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Rigel Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $69 → $81 | Strong Buy | Maintains | $69 → $81 | +186.22% | May 13, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $71 → $69 | Strong Buy | Maintains | $71 → $69 | +143.82% | May 7, 2026 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $23 → $42 | Hold → Strong Buy | Upgrades | $23 → $42 | +48.41% | Nov 5, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $32 → $38 | Hold | Maintains | $32 → $38 | +34.28% | Nov 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +101.41% | Oct 8, 2025 |
Financial Forecast
Revenue This Year
289.75M
from 294.28M
Decreased by -1.54%
Revenue Next Year
326.75M
from 289.75M
Increased by 12.77%
EPS This Year
4.21
from 19.48
Decreased by -78.41%
EPS Next Year
3.72
from 4.21
Decreased by -11.48%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 301.7M | 372.0M | ||||||
| Avg | 289.8M | 326.8M | ||||||
| Low | 274.9M | 300.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 2.5% | 28.4% | ||||||
| Avg | -1.5% | 12.8% | ||||||
| Low | -6.6% | 3.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 4.97 | 4.04 | ||||||
| Avg | 4.21 | 3.72 | ||||||
| Low | 3.54 | 3.42 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -74.5% | -3.9% | ||||||
| Avg | -78.4% | -11.5% | ||||||
| Low | -81.8% | -18.7% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.